Saturn V Capital Management Lp Top Holdings and 13F Report (2026) About Saturn V Capital Management LpInvestment ActivitySaturn V Capital Management Lp has $683.13 million in total holdings as of September 30, 2026.Saturn V Capital Management Lp owns shares of 24 different stocks, but just 13 companies or ETFs make up 80% of its holdings.Approximately 12.59% of the portfolio was purchased this quarter.About 3.64% of the portfolio was sold this quarter.This quarter, Saturn V Capital Management Lp has purchased 23 new stocks and bought additional shares in 14 stocks.Saturn V Capital Management Lp sold shares of 6 stocks and completely divested from 2 stocks this quarter.Largest Holdings Amylyx Pharmaceuticals $130,116,460ABIVAX SA $52,412,573Immix Biopharma $48,498,902Pharvaris $44,216,284Vaxcyte $43,941,480 Largest New Holdings this Quarter 90400D108 - Ultragenyx Pharmaceutical $11,404,328 Holding29479A108 - Erasca $7,539,770 Holding517954103 - LATIGO BIOTHERAPEUTICS INC $5,015,928 Holding Largest Purchases this Quarter Vir Biotechnology 1,269,779 shares (about $14.20M)Celcuity 143,529 shares (about $11.41M)Ultragenyx Pharmaceutical 758,771 shares (about $11.40M)ALTO NEUROSCIENCE INC 335,280 shares (about $8.56M)Erasca 514,309 shares (about $7.54M) Largest Sales this Quarter Vaxcyte 80,656 shares (about $4.59M)Amylyx Pharmaceuticals 152,745 shares (about $4.44M)DYNE THERAPEUTICS INC 220,318 shares (about $3.55M)Jazz Pharmaceuticals 10,598 shares (about $2.45M)ALUMIS INC 59,632 shares (about $440.68K) Sector Allocation Over TimeMap of 500 Largest Holdings ofSaturn V Capital Management Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorAMLXAmylyx Pharmaceuticals$130,116,460$4,444,880 ▼-3.3%4,471,35619.0%HealthcareABIVAX SA$52,412,573$1,034,561 ▲2.0%529,3137.7%SPONSORED ADSIMMXImmix Biopharma$48,498,902$27,948 ▲0.1%4,661,1157.1%HealthcarePHVSPharvaris$44,216,284$2,532,334 ▲6.1%1,393,9566.5%HealthcarePCVXVaxcyte$43,941,480$4,589,326 ▼-9.5%772,2586.4%HealthcareCELCCelcuity$40,861,113$11,413,426 ▲38.8%513,8476.0%HealthcareIRONDisc Medicine$40,104,789$5,755,963 ▲16.8%612,6615.9%HealthcareCADLCandel Therapeutics$36,291,591$1,801,109 ▲5.2%3,476,2065.3%HealthcareJAZZJazz Pharmaceuticals$34,806,717$2,453,649 ▼-6.6%150,3405.1%HealthcareMONOPAR THERAPEUTICS INC$24,884,924$29,797 ▲0.1%312,3503.6%COM NEWVIRVir Biotechnology$22,811,918$14,196,129 ▲164.8%2,040,4223.3%HealthcareTRVITrevi Therapeutics$22,537,904$7,472,648 ▲49.6%1,573,8763.3%HealthcareX4 PHARMACEUTICALS INC$21,362,682$1,139,987 ▲5.6%7,366,4423.1%COM NEWALUMIS INC$21,104,443$440,680 ▼-2.0%2,855,8113.1%COMSAGIMET BIOSCIENCES INC$19,787,792$5,166,202 ▲35.3%2,002,8132.9%COM SER ADYNE THERAPEUTICS INC$13,486,889$3,549,323 ▼-20.8%837,1752.0%COMALTO NEUROSCIENCE INC$13,227,323$8,559,699 ▲183.4%518,1091.9%COM SHSRAREUltragenyx Pharmaceutical$11,404,328$11,404,328 ▲New Holding758,7711.7%HealthcareZURAZura Bio$8,455,009$285,646 ▼-3.3%2,032,4541.2%HealthcareINHIBIKASE THERAPEUTICS INC$7,950,9100.0%3,869,0561.2%COM NEWOCSOculis$7,915,127$1,518,348 ▲23.7%847,4441.2%HealthcareERASErasca$7,539,770$7,539,770 ▲New Holding514,3091.1%HealthcareLATIGO BIOTHERAPEUTICS INC$5,015,928$5,015,928 ▲New Holding300,3550.7%COMSATELLOS BIOSCIENCE INC$4,392,800$1,417,800 ▲47.7%516,8000.6%COMIVVDInvivyd$0$7,321,432 ▼-100.0%00.0%HealthcareOVIDOvid Therapeutics$0$1,783,631 ▼-100.0%00.0%HealthcareShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.